Evidence map›Paper›PMID 20379136›Full record

ArticleThe EMBO journal2010

Nuclear deadenylation/polyadenylation factors regulate 3' processing in response to DNA damage.

Murat A Cevher, Xiaokan Zhang, Sully Fernandez, Sergey Kim, Jorge Baquero, Per Nilsson, Sean Lee, Anders Virtanen, Frida E Kleiman

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Murat A CevherDepartment of Chemistry, Hunter College, City University of New York, New York, NY, USA.
Xiaokan Zhang
Sully Fernandez
Sergey Kim
Jorge Baquero
Per Nilsson
Sean Lee
Anders Virtanen
Frida E Kleiman
Hunter College · USCity University of New York · USUppsala University · SENational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Physiological roles of Ewings Sarcoma gene product EWSZIADK056005 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI LEE, SEAN · 2009 to 2012
$1.7M
Mechanisms of Response to DNA Damage Nuclear FactorsSC1GM083806 · NIGMS · HUNTER COLLEGE · PI KLEIMAN, FRIDA E · 2008 to 2011
$1.4M
NIGMS NIH HHS SC1 GM083806NIGMS NIH HHS SC1GM083806
6 · The paper itself

Abstract

We previously showed that mRNA 3' end cleavage reaction in cell extracts is strongly but transiently inhibited under DNA-damaging conditions. The cleavage stimulation factor-50 (CstF-50) has a role in this response, providing a link between transcription-coupled RNA processing and DNA repair. In this study, we show that CstF-50 interacts with nuclear poly(A)-specific ribonuclease (PARN) using in vitro and in extracts of UV-exposed cells. The CstF-50/PARN complex formation has a role in the inhibition of 3' cleavage and activation of deadenylation upon DNA damage. Extending these results, we found that the tumour suppressor BARD1, which is involved in the UV-induced inhibition of 3' cleavage, strongly activates deadenylation by PARN in the presence of CstF-50, and that CstF-50/BARD1 can revert the cap-binding protein-80 (CBP80)-mediated inhibition of PARN activity. We also provide evidence that PARN along with the CstF/BARD1 complex participates in the regulation of endogenous transcripts under DNA-damaging conditions. We speculate that the interplay between polyadenylation, deadenylation and tumour-suppressor factors might prevent the expression of prematurely terminated messengers, contributing to control of gene expression under different cellular conditions.

Indexed as

DNA DamagePolyadenylationCell NucleusDNA RepairExoribonucleasesGene Expression RegulationGlutathione TransferaseHeLa CellsHumansModels, BiologicalmRNA Cleavage and Polyadenylation FactorsRecombinant ProteinsRNARNA, MessengerUltraviolet RaysExoribonucleasesGlutathione TransferasemRNA Cleavage and Polyadenylation FactorsRecombinant ProteinsRNARNA, Messenger

Identifiers

PMID20379136
PMCPMC2876964
OpenAlexW2076124785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.